Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8671 |
High Similarity |
NPD5761 |
Phase 2 |
0.8671 |
High Similarity |
NPD5760 |
Phase 2 |
0.8529 |
High Similarity |
NPD8434 |
Phase 2 |
0.8098 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7952 |
Intermediate Similarity |
NPD3749 |
Approved |
0.795 |
Intermediate Similarity |
NPD920 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7919 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7911 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7879 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7834 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7746 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7744 |
Intermediate Similarity |
NPD3226 |
Approved |
0.774 |
Intermediate Similarity |
NPD6785 |
Approved |
0.774 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7706 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7636 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7624 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD7236 |
Approved |
0.759 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7529 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5402 |
Approved |
0.75 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD919 |
Approved |
0.7484 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7469 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7457 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7457 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7453 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7438 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7398 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD37 |
Approved |
0.7396 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7368 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.736 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7299 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7251 |
Intermediate Similarity |
NPD2801 |
Approved |
0.725 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7228 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7215 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7213 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7191 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7184 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7159 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7119 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7088 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7088 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7062 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD17 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7043 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7041 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7032 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7011 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6975 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD447 |
Suspended |
0.6975 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6971 |
Remote Similarity |
NPD7057 |
Phase 3 |
0.6971 |
Remote Similarity |
NPD7058 |
Phase 2 |
0.697 |
Remote Similarity |
NPD5762 |
Approved |
0.697 |
Remote Similarity |
NPD5763 |
Approved |
0.6968 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6951 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD1778 |
Approved |
0.6946 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.694 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6937
|
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |